Parmax Pharma

Parmax Pharma Limited is an Indian pharmaceutical company specializing in manufacturing bulk drugs, drug intermediates, and various specialty chemicals for other businesses. The company is dedicated to enhancing stakeholder value by rigorously applying good corporate governance principles in line with legal and regulatory requirements. Its main objective is to make and sell products that create long-term, sustainable value for customers, shareholders, employees, and partners. The company actively monitors global industry changes, adapting its strategies to stay competitive in a dynamic environment. Furthermore, Parmax Pharma embraces innovation and change to propel itself forward as a potential global leader in its field. To facilitate modern investing, almost 73.13% of the company's shares were held in electronic dematerialized form as of March 31, 2024.;